{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:37:17Z","timestamp":1761489437523},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T00:00:00Z","timestamp":1408406400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001704","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T17:49:50Z","timestamp":1408470590000},"page":"e1001704","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations"],"prefix":"10.1371","volume":"11","author":[{"given":"Yoel","family":"Lubell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Varadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunmay","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phaik Yeong","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Maude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjen","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas P. J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4269\/ajtmh.12-0689","article-title":"The economic case for combating malaria","volume":"89","author":"M Purdy","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncomms2241","article-title":"Factors determining the occurrence of submicroscopic malaria infections and their relevance for control","volume":"3","author":"LC Okell","year":"2012","journal-title":"Nat Commun"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1475-2875-11-360","article-title":"Rationale for short course primaquine in Africa to interrupt malaria transmission","volume":"11","author":"AC Eziefula","year":"2012","journal-title":"Malar J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1469-0691.2011.03660.x","article-title":"The role of antimalarial treatment in the elimination of malaria","volume":"17","author":"RD Gosling","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e37166","DOI":"10.1371\/journal.pone.0037166","article-title":"Optimising strategies for Plasmodium falciparum malaria elimination in cambodia: Primaquine, mass drug administration and artemisinin resistance","volume":"7","author":"RJ Maude","year":"2012","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1475-2875-7-S1-S8","article-title":"The role of anti-malarial drugs in eliminating malaria","volume":"7","author":"NJ White","year":"2008","journal-title":"Malar J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","article-title":"Primaquine to prevent transmission of falciparum malaria","volume":"13","author":"NJ White","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map","volume":"9","author":"RE Howes","year":"2012","journal-title":"PLoS Med"},{"key":"ref9","unstructured":"World Health Organization Evidence Review Group (2012) The safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/malaria\/publications\/atoz\/who_pq_policy_recommendation\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/malaria\/publications\/atoz\/who_pq_policy_recommendation\/en\/<\/ext-link> Accessed 08 January 2014"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1475-2875-13-51","article-title":"Mass primaquine treatment to eliminate vivax malaria: lessons from the past","volume":"13","author":"A Kondrashin","year":"2014","journal-title":"Malar J"},{"key":"ref11","unstructured":"WHO (2013) World Malaria Report 2013. Geneva. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2013\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2013\/en\/<\/ext-link>. Accessed 08 January 2014."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"OM Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination, 1968","volume":"281","author":"JM Lane","year":"1969","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-200427010-00003","article-title":"Antimalarial drug toxicity: A review","volume":"27","author":"WR Taylor","year":"2004","journal-title":"Drug Saf"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.2105\/AJPH.91.11.1776","article-title":"An ethics framework for public health","volume":"91","author":"NE Kass","year":"2001","journal-title":"Am J Public Health"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pt.2010.08.005","article-title":"Consideration of ethics in primaquine therapy against malaria transmission","volume":"27","author":"JK Baird","year":"2011","journal-title":"Trends Parasitol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-12-418","article-title":"Spatial distribution of G6PD deficiency variants across malaria-endemic regions","volume":"12","author":"RE Howes","year":"2013","journal-title":"Malar J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0277-9536(95)00035-6","article-title":"Intimidation, coercion and resistance in the final stages of the South Asian Smallpox Eradication Campaign, 1973\u20131975","volume":"41","author":"P Greenough","year":"1995","journal-title":"Soc Sci Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1098\/rstb.2004.1486","article-title":"Informed consent and public health","volume":"359","author":"O O'Neill","year":"2004","journal-title":"Philosophical transactions of the Royal Society of London Series B, Biological sciences"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/phe\/phn001","article-title":"Ethics, tuberculosis and globalization","volume":"1","author":"MJ Selgelid","year":"2008","journal-title":"Public Health Ethics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(10)61963-0","article-title":"Artemisinin resistance\u2014the clock is ticking","volume":"376","author":"NJ White","year":"2010","journal-title":"Lancet"},{"key":"ref22","first-page":"215","article-title":"The Rejection of Consequentialism. 198 8) Consequentialism and Its Critics (Oxford: Oxford University Press)(1992a) Human Morality (Oxford: Oxford University Press) (1992b) \u201cPrerogatives Without Restrictions,\u201d","volume":"6","author":"S Scheffler","year":"1982","journal-title":"Philosophical Perspectives"},{"key":"ref23","unstructured":"WMA (2008) WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. 59th WMA General Assembly, Seoul, Korea: World Medical Association."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1308\/003588412X13171221501023","article-title":"The numeric threshold for the disclosure of risk: outdated and inapplicable to surgical consent","volume":"94","author":"R Wheeler","year":"2012","journal-title":"Ann R Coll Surg Engl"},{"key":"ref25","first-page":"740","article-title":"Structuring the issues in informed consent","volume":"26","author":"MA Somerville","year":"1980","journal-title":"McGill LJ"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.socscimed.2008.02.007","article-title":"Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya","volume":"67","author":"V Marsh","year":"2008","journal-title":"Social science & medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e45797","DOI":"10.1371\/journal.pone.0045797","article-title":"Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia","volume":"7","author":"S Hoyer","year":"2012","journal-title":"PLoS One"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:02:06Z","timestamp":1589025726000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001704","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,19]]}}}